Myocardial rupture epidemiology and demographics

Revision as of 14:13, 20 March 2013 by Michael Maddaleni (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Myocardial rupture Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Epidemiology and Demographics

Risk Factors

Relative Contribution of Myocardial Rupture as a Cause of Sudden Cardiac Death Following STEMI

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

ACC/AHA Guideline Recommendations

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myocardial rupture epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myocardial rupture epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myocardial rupture epidemiology and demographics

CDC on Myocardial rupture epidemiology and demographics

Myocardial rupture epidemiology and demographics in the news

Blogs on Myocardial rupture epidemiology and demographics

Directions to Hospitals Treating Myocardial rupture

Risk calculators and risk factors for Myocardial rupture epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

The incidence of myocardial rupture has decreased in the era of urgent revascularization and aggressive pharmacological therapy for the treatment of an acute myocardial rupture. However, the decrease in the incidence of myocardial rupture is not uniform; there is a slight increase in the incidence of rupture if thrombolytic agents are used to abort a myocardial infarction.[1] On the other hand, if primary percutaneous coronary intervention is performed to abort the infarction, the incidence of rupture is significantly lowered.[2] The incidence of myocardial rupture if PCI is performed in the setting of an acute myocardial infarction is about 1 percent.[3]

References

  1. Becker RC, Gore JM, Lambrew C, Weaver WD, Rubison RM, French WJ, Tiefenbrunn AJ, Bowlby LJ, Rogers WJ. (1996). "A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction". J Am Coll Cardiol. 27 (6): 1321–6. PMID 8626938.
  2. Moreno R, Lopez-Sendon J, Garcia E, Perez de Isla L, Lopez de Sa E, Ortega A, Moreno M, Rubio R, Soriano J, Abeytua M, Garcia-Fernandez MA. (2002). "Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction". J Am Coll Cardiol. 39 (4): 598–603. PMID 11849857.
  3. Yip HK, Wu CJ, Chang HW, Wang CP, Cheng CI, Chua S, Chen MC. (2003). "Cardiac rupture complicating acute myocardial infarction in the direct percutaneous coronary intervention reperfusion era" (PDF). Chest. 124 (2): 565–71. PMID 12907544.


Template:WikiDoc Sources